A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma
Summary Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to...
Saved in:
Published in | Investigational new drugs Vol. 38; no. 2; pp. 264 - 273 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.04.2020
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0167-6997 1573-0646 1573-0646 |
DOI | 10.1007/s10637-019-00779-3 |
Cover
Loading…
Abstract | Summary
Background
Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism.
Methods
The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells.
Results
Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling.
Conclusion
Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future. |
---|---|
AbstractList | Summary
Background
Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism.
Methods
The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells.
Results
Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling.
Conclusion
Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future. Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism. Methods The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells. Results Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling. Conclusion Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future.Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism. Methods The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells. Results Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling. Conclusion Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future. Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism. Methods The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells. Results Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling. Conclusion Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future. SummaryBackground Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal carcinoma (NPC) is still limited. The aims of this study were to investigate the anticancer effect of thiostrepton on NPC cells and to explore its underlying mechanism. Methods The effects of thiostrepton on the proliferation, migration, and invasion of NPC cells were investigated by a WST-1 assay, wound healing assay, and cell invasion assay, respectively. Microarrays were conducted and further analyzed by Ingenuity Pathways Analysis (IPA) to determine the molecular mechanism by which thiostrepton affects NPC cells. Results Our results showed that thiostrepton reduced NPC cell viability in a dose-dependent manner. Thiostrepton inhibited the migration and invasion of NPC cells in wound healing and cell invasion assays. The microarray data analyzed by IPA indicated the top 5 ingenuity canonical pathways, which were unfolded protein response, NRF2-mediated oxidative stress response, retinoate biosynthesis I, choline biosynthesis III, and pancreatic adenocarcinoma signaling. Conclusion Thiostrepton effectively suppressed NPC cell proliferation, migration, and invasion, likely by several mechanisms. Thiostrepton may be a potential therapeutic agent for treating NPC in the future. |
Author | Kuo, Yu-Lun Lan, Ming-Ying Hsu, Yen-Bin Huang, Chi-Ying F. Lan, Ming-Chin |
Author_xml | – sequence: 1 givenname: Yen-Bin surname: Hsu fullname: Hsu, Yen-Bin organization: Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Institute of Clinical Medicine, National Yang-Ming University – sequence: 2 givenname: Ming-Chin surname: Lan fullname: Lan, Ming-Chin organization: Department of Otolaryngology-Head and Neck Surgery, Buddhist Tzu Chi Medical Foundation, Taipei Tzu Chi Hospital, School of Medicine, Tzu Chi University – sequence: 3 givenname: Yu-Lun surname: Kuo fullname: Kuo, Yu-Lun organization: Biotools, Co., Ltd – sequence: 4 givenname: Chi-Ying F. surname: Huang fullname: Huang, Chi-Ying F. email: cyhuang5@ym.edu.tw organization: Institute of Clinical Medicine, National Yang-Ming University, Institute of Biopharmaceutical Sciences, National Yang-Ming University – sequence: 5 givenname: Ming-Ying orcidid: 0000-0001-5565-9580 surname: Lan fullname: Lan, Ming-Ying email: mingyinglan@gmail.com organization: Department of Otolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30993588$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9r3DAQxUVJaTZ_vkAPxdBLDnE7I8mWdQwhaQuBXtpTD0LWzjYKXsmV5EK_fbS7CYUcchIa_d7w9N4JOwoxEGPvET4hgPqcEXqhWkDd1qvSrXjDVtgp0UIv-yO2AuxV22utjtlJzg8AILSS79ixAK1FNwwr9uuqmRO5yQfv7NTQXzsttvgYmrhpyr2PuSSaSwyXjW2CLUuqlA3Fjz4W7y4bH-o4x_nepn_hN9VXZ5PzIW7tGXu7sVOm86fzlP28vflx_bW9-_7l2_XVXeukxNIOmwGkIyA7unXfIXSWd2rkFiTwAXeukUa-pt2cD71zclQ4kCbLgRSKU3Zx2Dun-GehXMzWZ0fTZAPFJRvOEXSHspMV_fgCfYhLCtXdnuKIPfBKfXiilnFLazMnv63fM8-xVWA4AC7FnBNtjPNlH1tJ1k8GwewaMoeGTG3I7Bsyokr5C-nz9ldF4iDKFa4pp_-2X1E9As2Zoic |
CitedBy_id | crossref_primary_10_1016_j_ejphar_2021_174661 crossref_primary_10_1002_cjoc_202100496 crossref_primary_10_1002_hed_27238 crossref_primary_10_1007_s10787_024_01587_9 crossref_primary_10_1039_D4RA01496K crossref_primary_10_1016_j_chembiol_2020_07_003 crossref_primary_10_69601_meandrosmdj_1540223 crossref_primary_10_1155_2019_7457013 |
Cites_doi | 10.4161/cc.8.12.8708 10.1371/journal.pone.0132839 10.1016/j.ajpath.2010.11.010 10.1158/1535-7163.MCT-08-0188 10.1002/path.2355 10.1002/ijc.28839 10.1007/s00432-014-1872-3 10.3892/or.2017.5480 10.1002/mc.22622 10.3892/mmr.2015.3469 10.1155/2010/930509 10.1158/1535-7163.MCT-09-0966 10.1007/s00066-015-0840-4 10.4161/cbt.11.1.13854 10.1158/0008-5472.CAN-05-3138 10.1186/s12944-018-0697-5 10.3892/or.2015.3834 10.1016/j.canlet.2016.01.040 10.1002/jgm.2614 10.1016/j.surg.2005.10.012 10.1158/1535-7163.MCT-11-0536 10.4161/cc.9.6.10955 10.1111/jcmm.12602 10.1038/emboj.2009.239 10.1101/gad.1200704 10.1016/j.ejphar.2016.06.052 10.1097/IGC.0000000000000969 10.1371/journal.pone.0005592 10.1039/C4QO00288A 10.1371/journal.pone.0006593 10.4161/cbt.13.3.18875 10.3892/or.2014.3357 10.1016/j.bcp.2012.01.027 10.1186/1476-4598-8-37 10.4161/cc.8.17.9414 10.1016/j.bbcan.2016.12.002 10.1007/978-3-540-92810-2 10.1002/hed.20833 10.1038/cddis.2015.155 10.1038/onc.2016.495 10.1158/0008-5472.CAN-05-3003 10.1158/0008-5472.CAN-05-2912 10.1093/nar/22.3.357 10.1038/nrc2223 10.1371/journal.pone.0004849 10.1158/0008-5472.CAN-04-4059 10.3109/03009734.2014.960053 10.1158/1541-7786.MCR-13-0008 10.18632/oncotarget.16147 10.18632/oncotarget.10078 10.18632/oncotarget.2957 10.1002/hed.23464 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2019 Investigational New Drugs is a copyright of Springer, (2019). All Rights Reserved. |
Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2019 – notice: Investigational New Drugs is a copyright of Springer, (2019). All Rights Reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7RV 7WY 7WZ 7X7 7XB 87Z 88E 8AO 8FD 8FI 8FJ 8FK 8FL ABUWG AFKRA AZQEC BENPR BEZIV CCPQU DWQXO FR3 FRNLG FYUFA F~G GHDGH K60 K6~ K9- K9. KB0 L.- M0C M0R M0S M1P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQBIZ PQBZA PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1007/s10637-019-00779-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Nursing & Allied Health Database ABI/INFORM Collection ABI/INFORM Global (PDF only) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Global (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Business Premium Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Business Premium Collection (Alumni) Health Research Premium Collection ABI/INFORM Global (Corporate) Health Research Premium Collection (Alumni) ProQuest Business Collection (Alumni Edition) ProQuest Business Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ABI/INFORM Professional Advanced ABI/INFORM Global Consumer Health Database Health & Medical Collection (Alumni) Medical Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ABI/INFORM Global (Corporate) ProQuest Business Collection (Alumni Edition) ProQuest One Business Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ABI/INFORM Complete ProQuest Central ABI/INFORM Professional Advanced ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Global ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Business Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Business (Alumni) ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ABI/INFORM Global (Corporate) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1573-0646 |
EndPage | 273 |
ExternalDocumentID | 30993588 10_1007_s10637_019_00779_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Taipei Veterans General Hospital grantid: V105-B–022 and V108C-088 funderid: http://dx.doi.org/10.13039/501100011912 – fundername: Ministry of Science and Technology, Taiwan grantid: MOST 106-2314-B-075 -035 -MY3; MOST 107-2320-B-010-040-MY3 funderid: http://dx.doi.org/10.13039/501100004663 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7WY 7X7 88E 8AO 8FI 8FJ 8FL 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BEZIV BGNMA BKEYQ BKNYI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRNLG FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GROUPED_ABI_INFORM_COMPLETE GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K60 K6~ K9- KDC KOV KOW KPH LAK LLZTM M0C M0R M1P M4Y MA- MK0 N2Q NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQBIZ PQBZA PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 WOW YLTOR Z45 Z7U Z81 Z82 Z87 Z8O Z8U Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QO 7XB 8FD 8FK ABRTQ FR3 K9. L.- P64 PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c441t-8f804ce0eabcd65105a257b2a04028100031eb2de5a25286cc4b718e9ea20e713 |
IEDL.DBID | 7X7 |
ISSN | 0167-6997 1573-0646 |
IngestDate | Tue Aug 05 10:18:44 EDT 2025 Sat Aug 23 12:42:40 EDT 2025 Thu Apr 03 06:55:27 EDT 2025 Tue Jul 01 03:15:30 EDT 2025 Thu Apr 24 23:07:30 EDT 2025 Fri Feb 21 02:33:57 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Nasopharyngeal carcinoma Anticancer drug Microarray Thiostrepton |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-8f804ce0eabcd65105a257b2a04028100031eb2de5a25286cc4b718e9ea20e713 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5565-9580 |
PMID | 30993588 |
PQID | 2210211602 |
PQPubID | 37283 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2210951454 proquest_journals_2210211602 pubmed_primary_30993588 crossref_citationtrail_10_1007_s10637_019_00779_3 crossref_primary_10_1007_s10637_019_00779_3 springer_journals_10_1007_s10637_019_00779_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-04-01 |
PublicationDateYYYYMMDD | 2020-04-01 |
PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationSubtitle | Novel Anti-Cancer Therapeutics and Therapies |
PublicationTitle | Investigational new drugs |
PublicationTitleAbbrev | Invest New Drugs |
PublicationTitleAlternate | Invest New Drugs |
PublicationYear | 2020 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Lu, Cooper, Lee (CR2) 2010 Lin, Wong, Chan, Tzung, Ho, Hsu, Chuang (CR22) 1990; 62 Kalin, Wang, Ackerson, Major, Detrisac, Kalinichenko, Lyubimov, Costa (CR31) 2006; 66 Westhoff, Chen, Teng (CR33) 2017; 27 Yin, Liu, Liu, Owzar, Han, Su, Wei, Hung, Brhane, McLaughlin, Brennan, Bickeboeller, Rosenberger, Houlston, Caporaso, Landi, Heinrich, Risch, Christiani, Amos, Wei (CR50) 2017; 56 Kim, Ackerson, Ramakrishna, Tretiakova, Wang, Kalin, Major, Gusarova, Yoder, Costa, Kalinichenko (CR30) 2006; 66 Chan, Yu, Chiu, Yao, Liu, Cheung, Ngan (CR32) 2008; 215 Lan, Chen, Lin, Lee, Yang (CR4) 2010; 9 Wonsey, Follettie (CR29) 2005; 65 Liu, Dai, Kang, Ban, Huang, Lang, Aldape, Xie, Pelloski, Xie, Sawaya, Huang (CR35) 2006; 66 Tang, Chen, Xue, He, Zheng, Zeng, Jia (CR1) 2016; 374 Qiao, Lamore, Cabello, Lesson, Muñoz-Rodriguez, Wondrak (CR40) 2012; 83 Lan, Yang, Lin, Lin, Shann, Ho, Huang (CR5) 2014; 36 Bhat, Halasi, Gartel (CR11) 2009; 4 Han, Jiang, Ma, Wu, Wang (CR48) 2018; 52 Wang, Jia, Xing, Li, Fan (CR37) 2015; 12 Loftus, Dhruv, Tuncali, Kloss, Yang, Schumacher, Cao, Williams, Eschbacher, Ross, Tran (CR54) 2013; 11 Zhou, Shen, Zheng, Wang, Che, Hu, Li (CR52) 2017; 8 Halasi, Zhao, Dahari, Bhat, Gonzalez, Lyubimo, Tonetti, Gartel (CR58) 2010; 9 Kalinichenko, Major, Wang, Petrovic, Kuechle, Yoder, Dennewitz, Shin, Datta, Raychaudhuri, Costa (CR28) 2004; 18 Chou, Lin, Kim, You, Xu, He, Jablons (CR3) 2008; 30 CR8 Verfaillie, Salazar, Velasco, Agostinis (CR43) 2010; 2010 Pandit, Bhat, Gartel (CR12) 2011; 11 Pandit, Gartel (CR13) 2011; 178 Park, Carr, Wang, Nogueira, Hay, Tyner, Lau, Costa, Raychaudhuri (CR25) 2009; 28 Sandu, Chandramouli, Glickman, Molina, Kuo, Kukushkin, Goldberg, Steller (CR41) 2015; 19 Wang, Gartel (CR55) 2011; 10 Hasanov, Chen, Chowdhury, Weldon, Ding, Jonasch, Sen, Walker, Dere (CR15) 2017; 36 Jiang, Wang, Chen (CR18) 2014; 119 Nuhn, Künzli, Hennig, Mitkus, Ramanauskas (CR45) 2009; 8 Yu, Chen, Yie, Wei, Wen (CR19) 2015; 33 Halasi, Schraufnagel, Gartel (CR56) 2009; 8 Douard, Moutereau, Pernet, Chimingqi, Allory, Manivet, Conti, Vaubourdolle, Cugnenc, Loric (CR34) 2006; 139 Halasi, Gartel (CR26) 2009; 8 Jo, Park, Kim (CR46) 2016; 788 Wang, Gartel (CR57) 2012; 13 Myatt, Lam (CR27) 2007; 7 Jiang, Wu, Wang, Wen, Yu, Wei, Chen (CR39) 2015; 141 Bhat, Halasi, Gartel (CR10) 2009; 4 Wang, Zheng, Wang, Zhao, Li, Yu, Wang, Liu (CR6) 2015; 2 Park, Lim, Ahn, Hwang (CR51) 2015; 10 Bhat, Chaudhary, Kumar, O'Malley, Inigo (CR44) 2017; 1867 Chiu, Huang, Tsai, Chen, Chang, Huang, Hsu, Chou (CR16) 2015; 6 Katoh, Katoh (CR24) 2004; 25 Jiang, Wang, Chen, Chen (CR17) 2014; 7 Schön, Flierman, Ofner, Stahringer, Holdt, Kolligs, Herbst (CR53) 2014; 135 Chen, Yang, Yu, Xie, Hu, Zeng, Tan (CR20) 2012; 14 Huang, Li, Luo, Hou, Zeng, Li, Mai, Zhang (CR21) 2015; 191 Ju, Huang, Huang, Su (CR14) 2015; 6 Zhu (CR36) 2014; 32 Rosendahl, Douthwaite (CR7) 1994; 22 Lin, Chan, Chen, Huang, Wu, Hsu, Chuang, Wang (CR23) 1993; 68 Gemenetzidis, Bose, Riaz, Chaplin, Young, Ali, Sugden, Thurlow, Cheong, Teo, Wan, Waseem, Parkinson, Fortune, Teh (CR38) 2009; 4 Jang, Hong, Kim, Kim, Jang, Park, Byun, Koh, Choi, Kae, Lee (CR47) 2016; 7 Qureshi, Zuvanich, Khan, Mushtaq, Silswal, Qureshi (CR42) 2018; 17 Kwok, Myatt, Marson, Coombes, Constantinidou, Lam (CR9) 2008; 7 Shiiba, Yamagami, Yamamoto, Minakawa, Okamoto, Kasamatsu, Sakamoto, Uzawa, Takiguchi, Tanzawa (CR49) 2017; 37 JJ Lu (779_CR2) 2010 HJ Park (779_CR25) 2009; 28 E Hasanov (779_CR15) 2017; 36 GL Westhoff (779_CR33) 2017; 27 IM Kim (779_CR30) 2006; 66 L Jiang (779_CR39) 2015; 141 EJ Jo (779_CR46) 2016; 788 R Douard (779_CR34) 2006; 139 SY Ju (779_CR14) 2015; 6 H Zhu (779_CR36) 2014; 32 UG Bhat (779_CR10) 2009; 4 VV Kalinichenko (779_CR28) 2004; 18 C Sandu (779_CR41) 2015; 19 MY Lan (779_CR4) 2010; 9 EM Park (779_CR51) 2015; 10 SF Wang (779_CR6) 2015; 2 L Jiang (779_CR17) 2014; 7 TV Kalin (779_CR31) 2006; 66 M Halasi (779_CR26) 2009; 8 B Pandit (779_CR12) 2011; 11 J Chou (779_CR3) 2008; 30 UG Bhat (779_CR11) 2009; 4 M Wang (779_CR55) 2011; 10 M Halasi (779_CR58) 2010; 9 DW Chan (779_CR32) 2008; 215 L Han (779_CR48) 2018; 52 T Verfaillie (779_CR43) 2010; 2010 M Halasi (779_CR56) 2009; 8 M Wang (779_CR57) 2012; 13 M Liu (779_CR35) 2006; 66 M Shiiba (779_CR49) 2017; 37 E Gemenetzidis (779_CR38) 2009; 4 JC Loftus (779_CR54) 2013; 11 AA Qureshi (779_CR42) 2018; 17 S Schön (779_CR53) 2014; 135 CT Lin (779_CR22) 1990; 62 S Zhou (779_CR52) 2017; 8 LL Tang (779_CR1) 2016; 374 MY Lan (779_CR5) 2014; 36 WT Chiu (779_CR16) 2015; 6 JM Kwok (779_CR9) 2008; 7 HJ Jang (779_CR47) 2016; 7 JY Wang (779_CR37) 2015; 12 779_CR8 TA Bhat (779_CR44) 2017; 1867 P Nuhn (779_CR45) 2009; 8 SS Myatt (779_CR27) 2007; 7 G Rosendahl (779_CR7) 1994; 22 H Chen (779_CR20) 2012; 14 L Jiang (779_CR18) 2014; 119 CT Lin (779_CR23) 1993; 68 J Yin (779_CR50) 2017; 56 S Qiao (779_CR40) 2012; 83 M Katoh (779_CR24) 2004; 25 PY Huang (779_CR21) 2015; 191 DR Wonsey (779_CR29) 2005; 65 B Pandit (779_CR13) 2011; 178 C Yu (779_CR19) 2015; 33 |
References_xml | – volume: 8 start-page: 1966 year: 2009 end-page: 1967 ident: CR26 article-title: A novel mode of FoxM1 regulation: positive auto-regulatory loop publication-title: Cell Cycle doi: 10.4161/cc.8.12.8708 – volume: 10 start-page: e0132839 year: 2015 ident: CR51 article-title: Interacts with nonstructural 4B and regulates hepatitis C virus propagation publication-title: PLoS One doi: 10.1371/journal.pone.0132839 – volume: 178 start-page: 355 year: 2011 end-page: 360 ident: CR13 article-title: Proteasome inhibitors induce p53-independent apoptosis in human cancer cells publication-title: Am J Pathol doi: 10.1016/j.ajpath.2010.11.010 – volume: 7 start-page: 2022 year: 2008 end-page: 2032 ident: CR9 article-title: Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-08-0188 – volume: 215 start-page: 245 year: 2008 end-page: 252 ident: CR32 article-title: Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis publication-title: J Pathol doi: 10.1002/path.2355 – volume: 135 start-page: 1800 year: 2014 end-page: 1811 ident: CR53 article-title: β-catenin regulates NF-κB activity via TNFRSF19 in colorectal cancer cells publication-title: Int J Cancer doi: 10.1002/ijc.28839 – volume: 52 start-page: 2101 year: 2018 end-page: 2109 ident: CR48 article-title: The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway publication-title: Int J Oncol – volume: 141 start-page: 971 year: 2015 end-page: 981 ident: CR39 article-title: Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-014-1872-3 – volume: 37 start-page: 2025 year: 2017 end-page: 2032 ident: CR49 article-title: Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity publication-title: Oncol Rep doi: 10.3892/or.2017.5480 – volume: 56 start-page: 1663 year: 2017 end-page: 1672 ident: CR50 article-title: Pathway-analysis of published genome-wide association studies of lung cancer: a potential role for the CYP4F3 locus publication-title: Mol Carcinog doi: 10.1002/mc.22622 – volume: 12 start-page: 1457 year: 2015 end-page: 1464 ident: CR37 article-title: Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3469 – volume: 2010 start-page: 930509 year: 2010 ident: CR43 article-title: Linking ER stress to autophagy: potential implications for Cancer therapy publication-title: Int J Cell Biol doi: 10.1155/2010/930509 – volume: 9 start-page: 2511 year: 2010 end-page: 2523 ident: CR4 article-title: From NPC therapeutic target identification to potential treatment strategy publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-09-0966 – ident: CR8 – volume: 36 start-page: 1398 year: 2014 end-page: 1407 ident: CR5 article-title: Using computational strategies to predict potential drugs for nasopharyngeal carcinoma publication-title: Head Neck – volume: 25 start-page: 1495 year: 2004 end-page: 1500 ident: CR24 article-title: Human FOX gene family (review) publication-title: Int J Oncol – volume: 191 start-page: 649 year: 2015 end-page: 655 ident: CR21 article-title: Expression of Aurora-B and FOXM1 predict poor survival in patients with nasopharyngeal carcinoma publication-title: Strahlenther Onkol doi: 10.1007/s00066-015-0840-4 – volume: 11 start-page: 43 year: 2011 end-page: 47 ident: CR12 article-title: Proteasome inhibitory activity of thiazole antibiotics publication-title: Cancer Biol Ther doi: 10.4161/cbt.11.1.13854 – volume: 66 start-page: 1712 year: 2006 end-page: 1720 ident: CR31 article-title: Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3138 – volume: 17 start-page: 62 year: 2018 ident: CR42 article-title: Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs publication-title: Lipids Health Dis doi: 10.1186/s12944-018-0697-5 – volume: 33 start-page: 2402 year: 2015 end-page: 2410 ident: CR19 article-title: Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial-to-mesenchymal transition pathway publication-title: Oncol Rep doi: 10.3892/or.2015.3834 – volume: 7 start-page: 46219 year: 2016 end-page: 46229 ident: CR47 article-title: Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer publication-title: Oncotarget – volume: 374 start-page: 22 year: 2016 end-page: 30 ident: CR1 article-title: Global trends in incidence and mortality of nasopharyngeal carcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2016.01.040 – volume: 14 start-page: 231 year: 2012 end-page: 240 ident: CR20 article-title: Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma publication-title: J Gene Med doi: 10.1002/jgm.2614 – volume: 139 start-page: 665 year: 2006 end-page: 670 ident: CR34 article-title: Sonic hedgehog-dependent proliferation in a series of patients with colorectal cancer publication-title: Surgery doi: 10.1016/j.surg.2005.10.012 – volume: 10 start-page: 2287 year: 2011 end-page: 2297 ident: CR55 article-title: Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-11-0536 – volume: 9 start-page: 1214 year: 2010 end-page: 1217 ident: CR58 article-title: Thiazole antibiotics against breast cancer publication-title: Cell Cycle doi: 10.4161/cc.9.6.10955 – volume: 7 start-page: 5450 year: 2014 end-page: 5460 ident: CR17 article-title: Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells publication-title: Int J Clin Exp Pathol – volume: 19 start-page: 2181 year: 2015 end-page: 2192 ident: CR41 article-title: Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates publication-title: J Cell Mol Med doi: 10.1111/jcmm.12602 – volume: 28 start-page: 2908 year: 2009 end-page: 2918 ident: CR25 article-title: FoxM1, a critical regulator of oxidative stress during oncogenesis publication-title: EMBO J doi: 10.1038/emboj.2009.239 – volume: 18 start-page: 830 year: 2004 end-page: 850 ident: CR28 article-title: Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor publication-title: Genes Dev doi: 10.1101/gad.1200704 – volume: 788 start-page: 321 year: 2016 end-page: 327 ident: CR46 article-title: Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2016.06.052 – volume: 27 start-page: 887 year: 2017 end-page: 894 ident: CR33 article-title: Targeting Foxm1 improves cytotoxicity of paclitaxel and cisplatinum in platinum-resistant ovarian Cancer publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000969 – volume: 4 year: 2009 ident: CR11 article-title: Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells publication-title: PLoS One doi: 10.1371/journal.pone.0005592 – volume: 8 start-page: 34652 year: 2017 end-page: 34660 ident: CR52 article-title: DNA methylation of METTL7A gene body regulates its transcriptional level in thyroid cancer publication-title: Oncotarget – volume: 2 start-page: 106 year: 2015 end-page: 109 ident: CR6 article-title: Target-oriented design and biosynthesis of Thiostrepton-derived thiopeptide antibiotics with improved pharmaceutical properties publication-title: Org Chem Front doi: 10.1039/C4QO00288A – volume: 4 start-page: e6593 year: 2009 ident: CR10 article-title: FoxM1 is a general target for proteasome inhibitors publication-title: PLoS One doi: 10.1371/journal.pone.0006593 – volume: 13 start-page: 184 year: 2012 end-page: 189 ident: CR57 article-title: Combination with bortezomib enhances the antitumor effects of nanoparticle-encapsulated thiostrepton publication-title: Cancer Biol Ther doi: 10.4161/cbt.13.3.18875 – volume: 32 start-page: 1327 year: 2014 end-page: 1334 ident: CR36 article-title: Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (review) publication-title: Oncol Rep doi: 10.3892/or.2014.3357 – volume: 83 start-page: 1229 year: 2012 end-page: 1240 ident: CR40 article-title: Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2012.01.027 – volume: 8 start-page: 37 year: 2009 ident: CR45 article-title: Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo publication-title: Mol Cancer doi: 10.1186/1476-4598-8-37 – volume: 8 start-page: 2850 year: 2009 end-page: 2851 ident: CR56 article-title: Wild-type p53 protects normal cells against apoptosis induced by thiostrepton publication-title: Cell Cycle doi: 10.4161/cc.8.17.9414 – volume: 1867 start-page: 58 year: 2017 end-page: 66 ident: CR44 article-title: Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2016.12.002 – year: 2010 ident: CR2 publication-title: Nasopharyngeal cancer: multidisciplinary management (medical radiology/radiation oncology) doi: 10.1007/978-3-540-92810-2 – volume: 30 start-page: 946 year: 2008 end-page: 963 ident: CR3 article-title: Nasopharyngeal carcinoma-- review of the molecular mechanisms of tumorigenesis publication-title: Head Neck doi: 10.1002/hed.20833 – volume: 6 start-page: e1801 year: 2015 ident: CR14 article-title: Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells publication-title: Cell Death Dis doi: 10.1038/cddis.2015.155 – volume: 6 start-page: 2349 year: 2015 end-page: 2365 ident: CR16 article-title: FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells publication-title: Oncotarget – volume: 36 start-page: 3450 year: 2017 end-page: 3463 ident: CR15 article-title: Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL publication-title: Oncogene doi: 10.1038/onc.2016.495 – volume: 66 start-page: 2153 year: 2006 end-page: 2161 ident: CR30 article-title: The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3003 – volume: 68 start-page: 716 year: 1993 end-page: 727 ident: CR23 article-title: Characterization of seven newly established nasopharyngeal carcinoma cell lines publication-title: Lab Investig – volume: 66 start-page: 3593 year: 2006 end-page: 3602 ident: CR35 article-title: FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2912 – volume: 22 start-page: 357 year: 1994 end-page: 363 ident: CR7 article-title: The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A publication-title: Nucleic Acids Res doi: 10.1093/nar/22.3.357 – volume: 7 start-page: 847 year: 2007 end-page: 859 ident: CR27 article-title: The emerging roles of forkhead box (Fox) proteins in cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc2223 – volume: 4 start-page: e4849 year: 2009 ident: CR38 article-title: FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation publication-title: PLoS One doi: 10.1371/journal.pone.0004849 – volume: 65 start-page: 5181 year: 2005 end-page: 5189 ident: CR29 article-title: Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4059 – volume: 62 start-page: 713 year: 1990 end-page: 724 ident: CR22 article-title: Establishment and characterization of two nasopharyngeal carcinoma cell lines publication-title: Lab Investig – volume: 119 start-page: 324 year: 2014 end-page: 332 ident: CR18 article-title: Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma publication-title: Ups J Med Sci doi: 10.3109/03009734.2014.960053 – volume: 11 start-page: 865 year: 2013 end-page: 874 ident: CR54 article-title: TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-13-0008 – volume: 30 start-page: 946 year: 2008 ident: 779_CR3 publication-title: Head Neck doi: 10.1002/hed.20833 – volume: 4 start-page: e6593 year: 2009 ident: 779_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0006593 – volume: 788 start-page: 321 year: 2016 ident: 779_CR46 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2016.06.052 – volume: 33 start-page: 2402 year: 2015 ident: 779_CR19 publication-title: Oncol Rep doi: 10.3892/or.2015.3834 – volume: 13 start-page: 184 year: 2012 ident: 779_CR57 publication-title: Cancer Biol Ther doi: 10.4161/cbt.13.3.18875 – volume: 178 start-page: 355 year: 2011 ident: 779_CR13 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2010.11.010 – volume: 2010 start-page: 930509 year: 2010 ident: 779_CR43 publication-title: Int J Cell Biol doi: 10.1155/2010/930509 – volume: 2 start-page: 106 year: 2015 ident: 779_CR6 publication-title: Org Chem Front doi: 10.1039/C4QO00288A – volume: 119 start-page: 324 year: 2014 ident: 779_CR18 publication-title: Ups J Med Sci doi: 10.3109/03009734.2014.960053 – volume: 141 start-page: 971 year: 2015 ident: 779_CR39 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-014-1872-3 – volume: 66 start-page: 3593 year: 2006 ident: 779_CR35 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2912 – volume: 374 start-page: 22 year: 2016 ident: 779_CR1 publication-title: Cancer Lett doi: 10.1016/j.canlet.2016.01.040 – volume: 9 start-page: 2511 year: 2010 ident: 779_CR4 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-09-0966 – volume: 12 start-page: 1457 year: 2015 ident: 779_CR37 publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3469 – volume: 9 start-page: 1214 year: 2010 ident: 779_CR58 publication-title: Cell Cycle doi: 10.4161/cc.9.6.10955 – volume: 8 start-page: 34652 year: 2017 ident: 779_CR52 publication-title: Oncotarget doi: 10.18632/oncotarget.16147 – volume: 215 start-page: 245 year: 2008 ident: 779_CR32 publication-title: J Pathol doi: 10.1002/path.2355 – volume: 7 start-page: 46219 year: 2016 ident: 779_CR47 publication-title: Oncotarget doi: 10.18632/oncotarget.10078 – volume: 7 start-page: 5450 year: 2014 ident: 779_CR17 publication-title: Int J Clin Exp Pathol – volume: 4 start-page: e4849 year: 2009 ident: 779_CR38 publication-title: PLoS One doi: 10.1371/journal.pone.0004849 – volume: 135 start-page: 1800 year: 2014 ident: 779_CR53 publication-title: Int J Cancer doi: 10.1002/ijc.28839 – volume: 10 start-page: 2287 year: 2011 ident: 779_CR55 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-11-0536 – volume: 6 start-page: e1801 year: 2015 ident: 779_CR14 publication-title: Cell Death Dis doi: 10.1038/cddis.2015.155 – volume: 19 start-page: 2181 year: 2015 ident: 779_CR41 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12602 – volume: 37 start-page: 2025 year: 2017 ident: 779_CR49 publication-title: Oncol Rep doi: 10.3892/or.2017.5480 – ident: 779_CR8 – volume: 25 start-page: 1495 year: 2004 ident: 779_CR24 publication-title: Int J Oncol – volume: 52 start-page: 2101 year: 2018 ident: 779_CR48 publication-title: Int J Oncol – volume: 191 start-page: 649 year: 2015 ident: 779_CR21 publication-title: Strahlenther Onkol doi: 10.1007/s00066-015-0840-4 – volume: 17 start-page: 62 year: 2018 ident: 779_CR42 publication-title: Lipids Health Dis doi: 10.1186/s12944-018-0697-5 – volume: 66 start-page: 2153 year: 2006 ident: 779_CR30 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3003 – volume: 11 start-page: 43 year: 2011 ident: 779_CR12 publication-title: Cancer Biol Ther doi: 10.4161/cbt.11.1.13854 – volume: 56 start-page: 1663 year: 2017 ident: 779_CR50 publication-title: Mol Carcinog doi: 10.1002/mc.22622 – volume: 68 start-page: 716 year: 1993 ident: 779_CR23 publication-title: Lab Investig – volume: 27 start-page: 887 year: 2017 ident: 779_CR33 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000969 – volume: 1867 start-page: 58 year: 2017 ident: 779_CR44 publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2016.12.002 – volume: 6 start-page: 2349 year: 2015 ident: 779_CR16 publication-title: Oncotarget doi: 10.18632/oncotarget.2957 – volume: 32 start-page: 1327 year: 2014 ident: 779_CR36 publication-title: Oncol Rep doi: 10.3892/or.2014.3357 – volume: 7 start-page: 847 year: 2007 ident: 779_CR27 publication-title: Nat Rev Cancer doi: 10.1038/nrc2223 – volume: 11 start-page: 865 year: 2013 ident: 779_CR54 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-13-0008 – volume: 36 start-page: 3450 year: 2017 ident: 779_CR15 publication-title: Oncogene doi: 10.1038/onc.2016.495 – volume: 10 start-page: e0132839 year: 2015 ident: 779_CR51 publication-title: PLoS One doi: 10.1371/journal.pone.0132839 – volume: 65 start-page: 5181 year: 2005 ident: 779_CR29 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4059 – volume: 36 start-page: 1398 year: 2014 ident: 779_CR5 publication-title: Head Neck doi: 10.1002/hed.23464 – volume: 83 start-page: 1229 year: 2012 ident: 779_CR40 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2012.01.027 – volume-title: Nasopharyngeal cancer: multidisciplinary management (medical radiology/radiation oncology) year: 2010 ident: 779_CR2 doi: 10.1007/978-3-540-92810-2 – volume: 66 start-page: 1712 year: 2006 ident: 779_CR31 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3138 – volume: 8 start-page: 37 year: 2009 ident: 779_CR45 publication-title: Mol Cancer doi: 10.1186/1476-4598-8-37 – volume: 18 start-page: 830 year: 2004 ident: 779_CR28 publication-title: Genes Dev doi: 10.1101/gad.1200704 – volume: 8 start-page: 1966 year: 2009 ident: 779_CR26 publication-title: Cell Cycle doi: 10.4161/cc.8.12.8708 – volume: 139 start-page: 665 year: 2006 ident: 779_CR34 publication-title: Surgery doi: 10.1016/j.surg.2005.10.012 – volume: 28 start-page: 2908 year: 2009 ident: 779_CR25 publication-title: EMBO J doi: 10.1038/emboj.2009.239 – volume: 62 start-page: 713 year: 1990 ident: 779_CR22 publication-title: Lab Investig – volume: 22 start-page: 357 year: 1994 ident: 779_CR7 publication-title: Nucleic Acids Res doi: 10.1093/nar/22.3.357 – volume: 14 start-page: 231 year: 2012 ident: 779_CR20 publication-title: J Gene Med doi: 10.1002/jgm.2614 – volume: 4 year: 2009 ident: 779_CR11 publication-title: PLoS One doi: 10.1371/journal.pone.0005592 – volume: 8 start-page: 2850 year: 2009 ident: 779_CR56 publication-title: Cell Cycle doi: 10.4161/cc.8.17.9414 – volume: 7 start-page: 2022 year: 2008 ident: 779_CR9 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-08-0188 |
SSID | ssj0003974 |
Score | 2.2980645 |
Snippet | Summary
Background
Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in... Background Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in nasopharyngeal... SummaryBackground Thiostrepton, a natural antibiotic, has recently been shown to be a potential anticancer drug for certain cancers, but its study in... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 264 |
SubjectTerms | Adenocarcinoma Anti-Bacterial Agents - pharmacology Antibiotics Anticancer properties Antineoplastic Agents - pharmacology Assaying Biosynthesis Cancer Cell Line, Tumor Cell migration Cell Movement - drug effects Cell proliferation Cell Proliferation - drug effects Cell Survival - drug effects Cell viability Cellular stress response Chemical compounds Choline Data processing Gene Expression Regulation, Neoplastic - drug effects Humans Medicine Medicine & Public Health Nasopharyngeal carcinoma Nasopharyngeal Carcinoma - drug therapy Nasopharyngeal Carcinoma - genetics Nasopharyngeal Neoplasms - drug therapy Nasopharyngeal Neoplasms - genetics Oncology Oxidative stress Pancreas Pancreatic cancer Pharmacology Pharmacology/Toxicology Preclinical Studies Protein folding Proteins Studies Thiostrepton Thiostrepton - pharmacology Throat cancer Wound healing |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEB58gHgRXV_riwjixQbaJM2mx0UUEVY8uCB4KEk2iwvaLu562H_vpE_FB3htpmnIZJJvOplvAM5CwV3Sc4w6YwQViZU0UUJTg96Eiq3lriDSHtzJm6G4fYwfq6SwWX3bvQ5JFjv1p2Q3yf01yYR6DpqE8mVYjdF39-t6yPrN_osnbMPoLZOkV6XK_NzH1-PoG8b8Fh8tjp3rTdio8CLplwregiWXdWBtUEXEO3B-X3JPLwLy0KZSzQJyTu5bVurFNjz1yRR3tyoRkrQs3yQfk_nzJPdZI1NEggHRpKD7RCmc9omZ5NhjQCYZPvZFD_TbAkeKrdbXIcryV70Dw-urh8sbWlVWoBbhz5yqsQqFdaHTxo6kx1gaTdcwjSbNlP_lzyN0uUfOP2dKWisMHmIucZqFDv3aXVjJ8sztAzFcSBOJSJuRFYhNTA_9Ujv2tDXSKS26ENUTnNqKdtxXv3hJW8Jkr5QUlZIWSkl5Fy6ad6Yl6caf0ke13tLKAGcp865sFMmQdeG0aUbT8fEQnbn8vZRBgCliHOReqe_mcxyRM4-V6kJQL4C289_HcvA_8UNYZ95_L24CHcHK_O3dHSPImZuTYk1_AJ6t8I8 priority: 102 providerName: Springer Nature |
Title | A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma |
URI | https://link.springer.com/article/10.1007/s10637-019-00779-3 https://www.ncbi.nlm.nih.gov/pubmed/30993588 https://www.proquest.com/docview/2210211602 https://www.proquest.com/docview/2210951454 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FsZextr9StcVDUZfZjFbUhT5qWQjXdloCaOBjD0YSVFoYLPTJn3If987W7EpZX0ySLIsfDrdd5LuO4BPqZIhHwTBg3OKq9xrnhtluUNvwvS9l6Em0j6_0GcT9WPan8YNt1W8VrldE-uFelZ52iP_Isg3yTKdipPlNaesUXS6GlNoPIVdoi4j52swbR2uFG1ty-2t83wQg2Zi6JyWdOky58Rok3N53zA9QJsPTkprA3T6El5E5MiGjaj34Eko9-HZeTwb34fjccNCvUnYZRdUtUrYMRt3_NSbV_BnyJa4zsWQSNbxfbNqztZXi4riR5aICRNmWU38ia1QAAu3qLDHhC1KLKb0B_ZmgyPFWk8Zicrqn30Nk9PR5bczHnMscI9AaM3N3KTKhzRY52ea0JZFJXbConILQ5v_MkPnexaoXBjtvXJozkIerEgDerhvYKesyvAOmJNKu0xl1s28QpTiBuih-jkR2OhgrOpBtv3BhY8E5JQH42_RUSeTUAoUSlELpZA9-Ny-s2zoNx5tfbiVWxFVcVV0E6cHH9tqVCI6GbFlqG6bNgg1VR8H-baRd_s5iRha9o3pQbKdAF3n_x_LweNjeQ_PBXnu9R2gQ9hZ39yGDwhv1u6onsNHsDv8_vvnCJ9fRxfjX1g6EcM7T7_3fQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Rb9MwED6NTgJeEAwYhQFGgr0Qa4ntus7DhAZs6thaVaiTJvEQbNcVlSApayfUP8Vv3DlxEqGJve3VdhzLdz5_Z_u-A3gbC-7SvmPUGSOoSK2kqRKaGvQmVM9a7koi7eFIDs7El_Pe-Qb8rWNh_LPK2iaWhnpaWH9Gvse8b5IkMmYfFr-pzxrlb1frFBqVWpy49R902Zb7x59Rvu8YOzqcfBrQkFWAWtz6V1TNVCysi502dio9vtCotoZpVGem_HE3T9DdnDpfzpS0Vhg04C51msUOfTrs9w5sCo5QoQObHw9H46-N7cfdvWETl2naD2E6IVhPcv_MM6WeQyel_N-t8Bq-vXY3W255Rw_hQcCq5KBSrkew4fItuDsMt_FbsDuueK_XEZm0YVzLiOySccuIvX4M3w7IAi1rCMIkLcM4KWZk9WNe-IiVBaLQiGhSUo1iKxT53MwL7DEi8xyLfcIFfbHGkWKt9TmQ8uKXfgJntzL_T6GTF7l7BsRwIU0iEm2mViAuMn30ie3MU-ZIp7ToQlJPcGYD5bnPvPEza8mavVAyFEpWCiXjXXjffLOoCD9ubL1Tyy0Li3-ZtarahTdNNS5bfxejc1dcVm0Q3IoeDnK7knfzO46onfeU6kJUK0Db-f_H8vzmsbyGe4PJ8DQ7PR6dvID7zJ8blC-QdqCzurh0LxFcrcyroNEEvt_2IroCf_QwuA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcEJSPLhQwEvRCrCa2N3EOCFWUVUtptYdWWolDsL1esRIkS3crtH-NX8dM4iRCFb31ajuO5RmP39ieNwBvYiV9nnnBvbWKq9ylPNfKcIvehB46J31NpH16lh5dqM-T4WQD_rSxMPSssrWJtaGeVo7OyPcF-SZJksZifxaeRYwPRx8WvzhlkKKb1jadRqMiJ379G9235fvjQ5T1WyFGn84_HvGQYYA7hAErrmc6Vs7H3lg3TQlrGFRhKwyqttB09C0TdD2nnsqFTp1TFo25z70RsUf_Dvu9A3czidsmrqVs0jl7Me7zHa94mudZCNgJYXuppAefOSc2nZzLfzfFa0j32i1tvfmNHsD9gFrZQaNmD2HDl9uwdRru5bdhb9wwYK8jdt4HdC0jtsfGPTf2-hF8PWALtLEhHJP1XOOsmrHV93lFsSsLxKMRM6wmHcVWKPy5nVfYY8TmJRZT6gVzucaRYq2jbEhl9dM8hotbmf0nsFlWpd8BZqVKbaISY6dOIUKyGXrHbkbkOanXRg0gaSe4cIH8nHJw_Ch62mYSSoFCKWqhFHIA77pvFg31x42td1u5FcEMLIteaQfwuqvGBUy3Mqb01VXTBmGuGuIgnzby7n4nEb_LodYDiFoF6Dv__1ie3TyWV7CFS6f4cnx28hzuCTpAqJ8i7cLm6vLKv0CUtbIva3Vm8O22189foh4ziA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+preclinical+evaluation+of+thiostrepton%2C+a+natural+antibiotic%2C+in+nasopharyngeal+carcinoma&rft.jtitle=Investigational+new+drugs&rft.au=Hsu%2C+Yen-Bin&rft.au=Lan%2C+Ming-Chin&rft.au=Kuo%2C+Yu-Lun&rft.au=Huang%2C+Chi-Ying+F&rft.date=2020-04-01&rft.eissn=1573-0646&rft.volume=38&rft.issue=2&rft.spage=264&rft_id=info:doi/10.1007%2Fs10637-019-00779-3&rft_id=info%3Apmid%2F30993588&rft.externalDocID=30993588 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6997&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6997&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6997&client=summon |